ExLibris header image
SFX Logo
Title: A biochemical rationale for the anticancer effects of Hsp90 inhibitors: Slow, tight binding inhibition by geldanamycin and its analogues
Source:

Proceedings of the National Academy of Sciences of the United States of America [0027-8424] Gooljarsingh, L T yr:2006


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Barker, Catherine R R. "Inhibition of Hsp90 acts synergistically with topoisomerase II poisons to increase the apoptotic killing of cells due to an increase in topoisomerase II mediated DNA damage." Nucleic Acids Research 34.4 (2006): 1148-57. Link to Full Text for this item Link to SFX for this item
2. Shen, G. "Design, Synthesis, and Structure-Activity Relationships for Chimeric Inhibitors of Hsp90." Journal of organic chemistry 71.20 (2006): 7618-7631. Link to Full Text for this item Link to SFX for this item
3. Sadikot, T. "Development and characterization of a novel C-terminal inhibitor of Hsp90 in androgen dependent and independent prostate cancer cells." BMC cancer 11.1 (2011): 468-468. Link to Full Text for this item Link to SFX for this item
4. Tak, Sung H. "Preparation and characterization of Apo2L/TNF-related apoptosis-inducing ligand-loaded human serum albumin nanoparticles with improved stability and tumor distribution." Journal of pharmaceutical sciences 100.2 (2011): 482-491. Link to Full Text for this item Link to SFX for this item
5. Arlander, Sonnet J H J. "Hsp90 inhibition depletes Chk1 and sensitizes tumor cells to replication stress." The Journal of biological chemistry 278.52 (2003): 52572-7. Link to SFX for this item
6. Yoshida K, Yamaguchi T, Shinagawa H, Taira N, Naka. "Protein Kinase C {delta} Activates Topoisomerase II{alpha} To Induce Apoptotic Cell Death in Response to DNA Damage." Molecular and cellular biology . Link to SFX for this item
7. Boland, M P. "Topoisomerase II is required for mitoxantrone to signal nuclear factor kappa B activation in HL60 cells." Journal of biological chemistry (2000): 25231-25238. Link to SFX for this item
8. Pearl, Laurence H. "Structure and mechanism of the Hsp90 molecular chaperone machinery." Annual review of biochemistry 75.1 (2006): 271-294. Link to Full Text for this item Link to SFX for this item
9. Hu, Y. "Scandenolone, a natural isoflavone derivative from Cudrania tricuspidata fruit, targets EGFR to induce apoptosis and block autophagy flux in human melanoma cells." Journal of Functional Foods 37 (2017): 229-240. Link to SFX for this item
10. Catley, L. "Proteasomal degradation of topoisomerase I is preceded by c-Jun NH2-terminal kinase activation, Fas up-regulation, and poly(ADP-ribose) polymerase cleavage in SN38-mediated cytotoxicity against multiple myeloma." Cancer research 64.23 (2004): 8746-53. Link to SFX for this item
11. O'Boyle, Niamh M. "Lead identification of beta-lactam and related imine inhibitors of the molecular chaperone heat shock protein 90." Bioorganic & medicinal chemistry 19.20 (2011): 6055-6068. Link to SFX for this item
12. Fan, Qing-Lin L. "Synergistic antitumor activity of TRAIL combined with chemotherapeutic agents in A549 cell lines in vitro and in vivo." Cancer chemotherapy and pharmacology 55.2 (2005): 189-196. Link to Full Text for this item Link to SFX for this item
13. Dominguez-Soto A, Angel A. "Dendritic Cell-Specific ICAM-3-Grabbing Nonintegrin Expression on M2-Polarized and Tumor-Associated Macrophages Is Macrophage-CSF Dependent and Enhanced by Tumor-Derived IL-6 and IL-10." The journal of immunology 186.4 (2011): 2192-2200. Link to SFX for this item
14. Bowman, K J J. "Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro." The British journal of cancer 84.1 (2001): 106-12. Link to Full Text for this item Link to SFX for this item
15. Yu, Jun N. "ATM, ATR and DNA-PK: initiators of the cellular genotoxic stress responses." Carcinogenesis 24.10 (2003): 1571-1580. Link to SFX for this item
16. Pettitt, K. R. "Hsp90 inhibition has opposing effects on wild-type and mutant p53 and induces p21 expression and cytotoxicity irrespective of p53/ATM status in chronic lymphocytic leukaemia cells." Oncogene 27.17 (2007): 2445-2455. Link to Full Text for this item Link to SFX for this item
17. Ward, B. "Interaction of the Hsp90 cochaperone cyclophilin 40 with Hsc70." Cell Stress & Chaperones 9.2 (2004): 167-181. Link to Full Text for this item Link to SFX for this item
18. KENDRICK, James E. "Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its therapeutic potential in breast and gynecologic cancers." Gynecologic Oncology 106.3 (2007): 614-21. Link to SFX for this item
19. Huang, R. "Efficient gene delivery targeted to the brain using a transferrin - conjugated polyethyleneglycol - modified polyamidoamine dendrimer." The FASEB journal 21.4 (2007): 1117-1125. Link to SFX for this item
20. Workman, P. "Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress." Annals of the New York Academy of Sciences 1113.1 (2007): 202-16. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.